AGIO Competitors & Alternatives
Compare Agios Pharm with similar stocks in the same industry
Biotechnology
AGIO
Main Stock$31.81
Tradestie Score
53
Market Cap
$2.33B
Revenue Growth
2.6%
Analyst Upside
+45.4%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$20.05
|
$2.18B | - | 65 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$14.05
|
$2.08B | - | 53 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$17.27
|
$2.02B | - | 49 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$12.22
|
$2.01B | - | 54 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$30.96
|
$1.97B | - | 52 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$7.01
|
$1.92B | - | 51 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$72.11
|
$1.92B | - | 45 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$28.82
|
$1.90B | 9.2 | 42 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$29.88
|
$1.84B | - | 51 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$29.71
|
$1.81B | - | 50 | Compare |
More AGIO Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry